Activities: The Spring Hope Cancer Foundation hosted a digital conference on December 3, 2020, from 6:00 pm to 8:00 pm, featuring Dr. Sajjan Rajpurohit and experts discussing Stage IV NSCLC management, Afatinib's role, TKI sequencing, and therapeutic updates for ALK+ mNSCLC. The event included panel discussions, Q&A sessions, and concluded with closing remarks, providing insights into cutting-edge lung cancer treatments.
Aim: The conference aimed to advance understanding and treatment strategies for Stage IV NSCLC, providing a clinical perspective on Afatinib's role, TKI sequencing, and therapeutic updates for ALK+ mNSCLC. Through expert discussions and panel sessions, the event seeks to enhance knowledge, and contribute to advancements in lung cancer management.
Impact: The conference advanced NSCLC treatment understanding and inspiring clinical application, potentially improving patient outcomes and contributing to ongoing research in lung cancer.
Knowledge Enhancement: Attendees gained insights into cutting-edge treatments for Stage IV NSCLC, including Afatinib's role and TKI sequencing.
Therapeutic Updates: Provided a comprehensive overview of recent therapeutic landscape updates for ALK+ mNSCLC.
Clinical Application: Fostered the application of new knowledge in clinical practice, potentially improving patient outcomes.
Contribution to Research: Inspired further research and advancements in lung cancer treatment through shared expertise and discussions.
Your donations are tax exempted under
80G of the Indian Income Tax Act.
Your donation transactions are
completely safe and secure.
Newsletter
